The pharma sector could be incentivized in the budget for adopting global practices & standards which enable counterfeit detection & authentication.
The vision of GS1 India is to significantly enhance patient safety through the elimination of medication errors, track & trace, product recalls, counterfeit detection & authentication of medicines & medical devices.
Ravi Mathur is the CEO of GS1 India
(Published 04 July 2019, 14:52 IST)
JOIN US